- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT06756646
Exploring the Effects of Aerobic Exercise Combined With BFRT on Patients With COPD
Exploring the Effects of Aerobic Exercise Combined With Blood Flow Restriction Training on Exercise Capacity, Cardiopulmonary Functions, and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease
Investigate the effects of exercise training on the cardiopulmonary function and exercise capacity in COPD patients.
Descripción general del estudio
Estado
Condiciones
Descripción detallada
The systemic effects of Chronic Obstructive Pulmonary Disease (COPD) can precipitate a series of complications, including cardiovascular disorders, muscle atrophy, and osteoporosis. These comorbid conditions often result in decreased physical activity and suboptimal physical fitness, compelling patients to lead a sedentary lifestyle to mitigate exercise-induced dyspnea. Addressing the limitations in exercise tolerance remains a critical therapeutic goal in the treatment of COPD. According to research, exercise intolerance is caused by both poor pulmonary function and associated skeletal muscle dysfunction. Blood flow restriction training, a new rehabilitation technique, has shown promise in improving muscular strength at lower exercise intensities and in shorter timeframes, presenting a fresh approach to COPD rehabilitation.
The research aims to investigate the impact of incorporating blood flow restriction training into a holistic aerobic exercise program on exercise capacity and quality of life among patients with COPD. The findings are intended to clarify the potential of this innovative training technique as a supplementary therapeutic strategy in the management of COPD.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Kun-Ling Tsai, Ph.D.
- Número de teléfono: 5078 886-6-2353535
- Correo electrónico: kunlingtsai@mail.ncku.edu.tw
Copia de seguridad de contactos de estudio
- Nombre: Yu-Ting Huang, M.S.
- Número de teléfono: 5078 886-6-2353535
- Correo electrónico: t66061053@pt.ncku.edu.tw
Ubicaciones de estudio
-
-
Taiwan
-
Tainan, Taiwan, Taiwán, 701
- Reclutamiento
- National Cheng Kung University Hostipal
-
Contacto:
- Kun-Ling Tsai, PhD
- Número de teléfono: 6219 062353535
- Correo electrónico: kunlingtsai@mail.ncku.edu.tw
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- COPD classified as levels 2-4.
- Stable condition without worsening in the past three months.
- No participation in any rehabilitation program within the past six months.
- Ability to understand and follow verbal commands and cooperate with an exercise training program.
Exclusion Criteria:
- Unconscious or unable to cooperate with the evaluator.
- Hospitalization due to acute illness within the past three months.
- Severe joint diseases or history of lower limb surgery.
- Severe cardiovascular disease (e.g., presence of a cardiac pacemaker or acute myocardial infarction within the past six months).
- Dependence on oxygen supply.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Usual care group
The Usual care group will receive COPD and exercise-related education. |
The participants will be provided by educational program about COPD self-care and home-based exercise approach. |
|
Experimental: Aerobic exercise group-cycling
The aerobic exercise group will receive cycling training intervention 2-3 times per week for 2 months. |
The aerobic exercise intervention will utilize an ergometer. The program will be conducted 2-3 times per week over a 3-month period. |
|
Experimental: BFR group-cycling + BFR
The BFR group will receive cycling training combined with BFR intervention 2-3 times per week for 2 months. |
Blood flow restriction (BFR) intervention will combine aerobic exercise on the ergometer with BFR training. The program will be conducted 2-3 times per week over a 3-month period. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Oxygen consumption (VO2)
Periodo de tiempo: Change from baseline (0 week) to follow up (20 weeks)
|
Oxygen consumption examined by cardiopulmonary exercise test |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Functional capacity
Periodo de tiempo: Change from baseline (0 week) to follow up (20 weeks)
|
Functional capacity examined by 6MWT |
Change from baseline (0 week) to follow up (20 weeks)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Heart Rate Variability
Periodo de tiempo: Change from baseline (0 week) to follow up (20 weeks)
|
Heart Rate Variability examined by autonomic nervous system |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Pulmonary function test
Periodo de tiempo: Change from baseline (0 week) to follow up (20 weeks)
|
Pulmonary function test examined by spirometer. Spirometry is a physiological test that measures the ability to inhale and exhale air over time. The main spirometry results are forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), and the FEV1/FVC ratio. |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Maximum respiratory pressure
Periodo de tiempo: Change from baseline (0 week) to follow up (20 weeks)
|
Maximum respiratory pressure examined by pressure meter |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-I)
Periodo de tiempo: Change from baseline (0 week) to follow up (20 weeks)
|
Quality of life score examined by mMRC Questionnaire. |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-II)
Periodo de tiempo: Change from baseline (0 week) to follow up (20 weeks)
|
COPD Assessment Test (CAT) questionaire |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-III)
Periodo de tiempo: Change from baseline (0 week) to follow up (20 weeks)
|
St George's Respiratory Questionnaire (SGRQ) |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Diaphragm capacity
Periodo de tiempo: Change from baseline (0 week) to follow up (20 weeks)
|
Diaphragm capacity examined by diaphragmatic ultrasound |
Change from baseline (0 week) to follow up (20 weeks)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Kun-Ling Tsai, Ph.D., Department of Physical Therapy, National Cheng Kung University
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- B-ER-113-298
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
IPD sharing plan will be decided after summarized data being published.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .